Printer Friendly

MyHeritage announces new distribution centre in Tilburg, the Netherlands to meet rapidly expanding customer base in Europe.

M2 PHARMA-July 2, 2018-MyHeritage announces new distribution centre in Tilburg, the Netherlands to meet rapidly expanding customer base in Europe


DNA testing company MyHeritage revealed on Friday the inauguration of its new distribution centre in Tilburg, the Netherlands for shipments of its DNA testing kits to Europe.

Following the opening of the new distribution centre in Tilburg, the Netherlands, the DNA kits ordered by European customers are now being shipped to them directly from Europe, instead of the USA. Delivery time across Europe via standard shipping now takes less than a week and is even faster to the Netherlands, Belgium, Germany and Denmark. Expedited shipping is available throughout Europe. Shipping costs to Europe are now much lower for consumers than before.

The company's new distribution centre covers most countries in Europe, except Poland, where MyHeritage DNA kits are not sold and except for non-EU countries Norway and Switzerland, which are still served from its fulfilment centre in the USA.

Additionally, the new distribution centre will collect DNA samples sent back by European customers and rush them to the MyHeritage DNA lab in the USA.

According to the company, the MyHeritage DNA kits can be purchased online at MyHeritage is the best choice for European DNA matching, enabling users to find relatives in Europe through shared DNA. Having a large European customer base is a substantial benefit for people seeking to find their relatives in Europe and for people in the USA and the rest of the world whose ancestors originated from Europe.

((Comments on this story may be sent to

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Geographic Code:4EUNE
Date:Jul 2, 2018
Previous Article:Pulmonx Corp receives US FDA approval for Zephyr Endobronchial Valve System for treating severe emphysema patients.
Next Article:Genmab reports triggering of milestone payment to Seattle Genetics under HuMax-AXL-ADC development programme.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |